Effect of Azathioprine on Na + /H + exchanger activity in dendritic cells

Cellular Physiology and Biochemistry

Volumn 29, Issue 3-4, 2012, Pages 533-542

  Bhandaru, Madhuri ^a   Pasham, Venkanna ^a   Yang, Wenting ^a   Bobbala, Diwakar ^a   Rotte, Anand ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Cell volume; Migration; Oxidative stress

Indexed keywords

AMMONIA; AZATHIOPRINE; BACTERIUM LIPOPOLYSACCHARIDE; DICHLORODIHYDROFLUORESCEIN DIACETATE; FLUORESCENT DYE; REACTIVE OXYGEN METABOLITE; SODIUM ION; SODIUM PROTON EXCHANGE PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ALKALINIZATION; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE MARROW CELL; CELL ISOLATION; CELL MIGRATION; CELL PH; CELL SWELLING; CELL VOLUME; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOSOL; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE; FLUORESCENCE ACTIVATED CELL SORTING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTON SODIUM EXCHANGE;

BACTERIA (MICROORGANISMS); MURINAE;

EID: 84859914401     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000338507     Document Type: Article

References (96)

1. Anstey A, Lear JT: Azathioprine: clinical pharmacology and current indications in autoimmune disorders. BioDrugs 1998;9:33-47. (Pubitemid 28053763)
2. Casetta I, Iuliano G, Filippini G: Azathioprine for multiple sclerosis. Cochrane Database Syst Rev 2007;(4):CD003982.
3. Hollander AA, van der Woude FJ: Efficacy and tolerability of conversion from cyclosporin to azathioprine after kidney transplantation: a review of the evidence. BioDrugs 1998;9:197-210. (Pubitemid 28161243)
4. Wise M, Callen JP: Azathioprine: a guide for the management of dermatology patients. Dermatol Ther 2007;20:206-215. (Pubitemid 350029310)
5. Bojic D, Radojicic Z, Nedeljkovic-Protic M, Al Ali M, Jewell DP, Travis SP: Longterm outcome after admission for acute severe ulcerative colitis in Oxford: the 1992-1993 cohort. Inflamm Bowel Dis 2009;15:823-828.
6. Chebli LA, Chaves LD, Pimentel FF, Guerra DM, Barros RM, Gaburri PD, Zanini A, Chebli JM: Azathioprine maintains long-term steroid-free remission through 3 years in patients with steroid-dependent ulcerative colitis. Inflamm Bowel Dis 2010;16:613-619.
7. Lopez-Serrano P, Perez-Calle JL, Fernandez-Rodriguez C: Ulcerative colitis in Madrid, Spain: current management. Inflamm Bowel Dis 2010;16:1826-1827.
8. Prefontaine E, Macdonald JK, Sutherland LR: Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2010;CD000545.
9. Riello L, Talbotec C, Garnier-Lengline H, Pigneur B, Svahn J, Canioni D, oulet O, Schmitz J, Ruemmele FM: Tolerance and efficacy of azathioprine in pediatric Crohn's disease. Inflamm Bowel Dis 2011;17:2138-2143.
10. Ruffolo C, Scarpa M, Bassi N: Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med 2010;363:1086-1087.
11. Sokol H, Beaugerie L: Body mass index and disease activity at treatment initiation: potential new predictors of response to azathioprine therapy in IBD. Inflamm Bowel Dis 2010;16:714-715.
12. Thia KT, Li M, Ling KL, Kong SC, Ooi CJ: Azathioprine is effective in corticosteroid-dependent Asian inflammatory bowel disease patients. Inflamm Bowel Dis 2011;17:809-815.
13. Jaspers GJ, Verkade HJ, Escher JC, de Ridder L, Taminiau JA, Rings EH: Azathioprine maintains first remission in newly diagnosed pediatric Crohn's disease. Inflamm Bowel Dis 2006;12:831-836. (Pubitemid 44352709)
14. Mantzaris GJ, Roussos A, Kalantzis C, Koilakou S, Raptis N, Kalantzis N: How adherent to treatment with azathioprine are patients with Crohn's disease in longterm remission? Inflamm Bowel Dis 2007;13:446-450. (Pubitemid 46668250)
15. Mendoza JL, Urcelay E, Lana R, Martin MC, Lopez N, Guijarro LG, Mayol JA, Taxonera C, de la Concha EG, Pena AS, Diaz-Rubio M: MDR1 polymorphisms and response to azathioprine therapy in patients with Crohn's disease. Inflamm Bowel Dis 2007;13:585-590. (Pubitemid 46799643)
16. Morales A, Salguti S, Miao CL, Lewis JD: Relationship between 6-mercaptopurine dose and 6-thioguanine nucleotide levels in patients with inflammatory bowel disease. Inflamm Bowel Dis 2007;13:380-385. (Pubitemid 46668241)
17. Swidsinski A, Loening-Baucke V, Bengmark S, Lochs H, Dorffel Y: Azathioprine and mesalazine-induced effects on the mucosal flora in patients with IBD colitis. Inflamm Bowel Dis 2007;13:51-56. (Pubitemid 46080009)
18. Thomas CW Jr, Lowry PW, Franklin CL, Weaver AL, Myhre GM, Mays DC, Tremaine WJ, Lipsky JJ, Sandborn WJ: Erythrocyte mean corpuscular volume as a surrogate marker for 6-thioguanine nucleotide concentration monitoring in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine. Inflamm Bowel Dis 2003;9:237-245.
19. Dubinsky MC: Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety. Clin Gastroenterol Hepatol 2004;2:731-743. (Pubitemid 39200711)
20. Mountz JD, Wu J, Cheng J, Zhou T: Autoimmune disease. A problem of defective apoptosis. Arthritis Rheum 1994;37:1415-1420. (Pubitemid 24337682)
21. Thomas CW, Myhre GM, Tschumper R, Sreekumar R, Jelinek D, McKean DJ, Lipsky JJ, Sandborn WJ, Egan LJ: Selective inhibition of inflammatory gene expression in activated T lymphocytes: a mechanism of immune suppression by thiopurines. J Pharmacol Exp Ther 2005;312:537-545. (Pubitemid 40189550)
22. Tiede I, Fritz G, Strand S, Poppe D, Dvorsky R, Strand D, Lehr HA, Wirtz S, Becker C, Atreya R, Mudter J, Hildner K, Bartsch B, Holtmann M, Blumberg R, Walczak H, Iven H, Galle PR, Ahmadian MR, Neurath MF: CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes. J Clin Invest 2003;111:1133-1145. (Pubitemid 36519931)
23. Aldinucci A, Biagioli T, Manuelli C, Repice AM, Massacesi L, Ballerini C: Modulating dendritic cells (DC) from immunogenic to tolerogenic responses: a novel mechanism of AZA/6-MP. JNeuroimmunol 2010;218:28-35.
24. Ng SC, Plamondon S, Kamm MA, Hart AL, Al Hassi HO, Guenther T, Stagg AJ, Knight SC: Immunosuppressive effects via human intestinal dendritic cells of probiotic bacteria and steroids in the treatment of acute ulcerative colitis. Inflamm Bowel Dis 2010;16:1286-1298.
25. Adler HS, Steinbrink K: Tolerogenic dendritic cells in health and disease: friend and foe! Eur J Dermatol 2007;17:476-491. (Pubitemid 350207158)
26. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K: Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811. (Pubitemid 30365397)
27. van Duivenvoorde LM, Han WG, Bakker AM, Louis-Plence P, Charbonnier LM, Apparailly F, van der Voort EI, Jorgensen C, Huizinga TW, Toes RE: Immunomodulatory dendritic cells inhibit Th1 responses and arthritis via different mechanisms. J Immunol 2007;179:1506-1515.
28. Forster R, Davalos-Misslitz AC, Rot A: CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol 2008;8:362-371. (Pubitemid 351595218)
29. Riccardi C, Bruscoli S, Migliorati G: Molecular mechanisms of immunomodulatory activity of glucocorticoids. Pharmacol Res 2002;45:361-368. (Pubitemid 35304501)
30. Bergamo P, Maurano F, D'Arienzo R, David C, Rossi M: Association between activation of phase 2 enzymes and downregulation of dendritic cell maturation by c9,t11-conjugated linoleic acid. Immunol Lett 2008;117:181-190.
31. Matsue H, Edelbaum D, Shalhevet D, Mizumoto N, Yang C, Mummert ME, Oeda J, Masayasu H, Takashima A: Generation and function of reactive oxygen species in dendritic cells during antigen presentation. J Immunol 2003;171:3010-3018. (Pubitemid 37093524)
32. Yamada H, Arai T, Endo N, Yamashita K, Fukuda K, Sasada M, Uchiyama T: LPS-induced ROS generation and changes in glutathione level and their relation to the maturation of human monocytederived dendritic cells. Life Sci 2006;78:926-933. (Pubitemid 43112529)
33. Rada BK, Geiszt M, Kaldi K, Timar C, Ligeti E: Dual role of phagocytic NADPH oxidase in bacterial killing. Blood 2004;104:2947-2953. (Pubitemid 39434986)
34. Garciarena CD, Caldiz CI, Correa MV, Schinella GR, Mosca SM, Chiappe de Cingolani GE, Cingolani HE, Ennis IL: Na+/H++ exchanger-1 inhibitors decrease myocardial superoxide production via direct mitochondrial action. J Appl Physiol 2008;105:1706-1713.
35. De Vito P: The sodium/hydrogen exchanger: a possible mediator of immunity. Cell Immunol 2006;240:69-85. (Pubitemid 44353444)
36. Henderson LM, Chappell JB, Jones OT: Internal pH changes associated with the activity of NADPH oxidase of human neutrophils. Further evidence for the presence of an H+ conducting channel. Biochem J 1988;251:563-567.
37. Swallow CJ, Grinstein S, Sudsbury RA, Rotstein OD: Relative roles of Na+/H+ exchange and vacuolar-type H+ ATPases in regulating cytoplasmic pH and function in murine peritoneal macrophages. J Cell Physiol 1993;157:453-460. (Pubitemid 23361173)
38. Putney LK, Denker SP, Barber DL: The changing face of the Na+/H+ xchanger, NHE1: structure, regulation, and cellular actions. Annu Rev Pharmacol Toxicol 2002;42:527-552.
39. Zachos NC, Tse M, Donowitz M: Molecular physiology of intestinal Na+/ H+ exchange. Annu Rev Physiol 2005;67:411-443.
40. Bidani A, Brown SE, Heming TA, Gurich R, Dubose TD Jr: Cytoplasmic pH in pulmonary macrophages: recovery from acid load is Na+ independent and NEM sensitive. Am J Physiol 1989;257:C65-C76.
41. Bidani A, Brown SE, Heming TA: pHi regulation in alveolar macrophages: relative roles of Na+-H+ antiport and H+-ATPase. Am J Physiol 1994;266:L681-L688.
42. DeCoursey TE, Cherny VV: Voltageactivated proton currents in human THP-1 monocytes. J Membr Biol 1996;152:131-140. (Pubitemid 26266045)
43. Heming TA, Bidani A: Na+-H+ exchange in resident alveolar macrophages: activation by osmotic cell shrinkage. J Leukoc Biol 1995;57:609-616.
44. Heming TA, Bidani A: Plasmalemmal H+ extruders in mammalian alveolar macrophages. Comp Biochem Physiol A Mol Integr Physiol 2002;133:143-150. (Pubitemid 34879708)
45. Lardner A: The effects of extracellular pH on immune function. J Leukoc Biol 2001;69:522-530. (Pubitemid 32294836)
46. Swallow CJ, Grinstein S, Rotstein OD: Regulation and functional significance f cytoplasmic pH in phagocytic leukocytes; in Grinstein S, Rotstein OD (eds): Mechanisms of leukocytes activation, Current Topics in Membranes and Transport. New York, Academic Press, Inc., 1990, pp 227-247
47. Swallow CJ, Grinstein S, Sudsbury RA, Rotstein OD: Cytoplasmic pH regulation in monocytes and macrophages: mechanisms and functional implications. Clin Invest Med 1991;14:367-378.
48. Forsbeck K, Nygren P, Larsson R, Nilsson M, Nilsson K, Gylfe E: Cytoplasmic pH is differently regulated in the monoblastic U-937 and erythroleukemic K-562 cell lines. Exp Cell Res 1988;176:96-106.
49. Ladoux A, Damais C, Krawice I, Abita JP, Frelin C: An increase in intracellular pH is a general response of promonocytic cells to differentiating agents. FEBS Lett 1988;234:353-356.
50. Rotte A, Pasham V, Eichenmuller M, Mahmud H, Xuan NT, Shumilina E, Gotz F, Lang F: Effect of bacterial lipopolysaccharide on Na/H+ exchanger activity in dendritic cells. Cell Physiol Biochem 2010;26:553-562.
51. Rotte A, Pasham V, Yang W, Eichenmuller M, Bhandaru M, Shumilina E, Lang F: Phosphoinositide 3-kinasedependent regulation of Na+/H+ exchanger in dendritic cells. Pflugers Arch 2010;460:1087-1096.
52. Hoffmann EK, Lambert IH, Pedersen SF: Physiology of cell volume regulation in vertebrates. Physiol Rev 2009;89:193-277.
53. Lang F, Busch GL, Ritter M, Volkl H, Waldegger S, Gulbins E, Haussinger D: Functional significance of cell volume regulatory mechanisms. Physiol Rev 1998;78:247-306. (Pubitemid 28070981)
54. Choi CH, Patel H, Barber DL: Expression of actin-interacting protein 1 suppresses impaired chemotaxis of Dictyostelium cells lacking the Na+-H+ exchanger NHE1. Mol Biol Cell 2010;21:3162-3170.
55. Koliakos G, Paletas K, Kaloyianni M: NHE-1: a molecular target for signaling and cell matrix interactions. Connect Tissue Res 2008;49:157-161.
56. Zolota Z, Koliakos G, Paletas K, Kaloyianni M: NHE-1 and beta 1 integrin dependent monocyte adhesion and migration after glucose, insulin or PPARgamma stimulation. Cell Adh Migr 2011;5:258-265.
57. Aki D, Minoda Y, Yoshida H, Watanabe S, Yoshida R, Takaesu G, Chinen T, Inaba T, Hikida M, Kurosaki T, Saeki K, Yoshimura A: Peptidoglycan and lipopolysaccharide activate PLCgamma2, leading to enhanced cytokine production in macrophages and dendritic cells. Genes Cells 2008;13:199-208. (Pubitemid 351188989)
58. Matzner N, Zemtsova IM, Nguyen TX, Duszenko M, Shumilina E, Lang F: Ion channels modulating mouse dendritic cell functions. J Immunol 2008;181:6803-6809.
59. Xuan NT, Shumilina E, Matzner N, Zemtsova IM, Biedermann T, Goetz F, Lang F: Ca2+-dependent functions in peptidoglycan-stimulated mouse dendritic cells. Cell Physiol Biochem 2009;24:167-176.
60. Xuan NT, Shumilina E, Qadri SM, Gotz F, Lang F: Effect of thymoquinone on mouse dendritic cells. Cell Physiol Biochem 2010;25:307-314.
61. Xuan NT, Shumilina E, Nasir O, Bobbala D, Gotz F, Lang F: Stimulation of ouse dendritic cells by Gum Arabic. Cell Physiol Biochem 2010;25:641-648.
62. Bobbala D, Koka S, Geiger C, Foller M, Huber SM, Lang F: Azathioprine favourably influences the course of malaria. Malar J 2009;8:102.
63. Geiger C, Foller M, Herrlinger KR, Lang F: Azathioprine-induced suicidal erythrocyte death. Inflamm Bowel Dis 2008;14:1027-1032.
64. Sinha A, Singh A, Satchidanandam V, Natarajan K: Impaired generation of reactive oxygen species during differentiation of dendritic cells (DCs) by Mycobacterium tuberculosis secretory antigen (MTSA) and subsequent activation of MTSA-DCs by mycobacteria results in increased intracellular survival. J Immunol 2006;177:468-478. (Pubitemid 43939160)
65. Waisbren SJ, Geibel J, Boron WF, Modlin IM: Luminal perfusion of isolated gastric glands. Am J Physiol 1994;266:C1013-C1027.
66. Roos A, Boron WF: Intracellular pH. Physiol Rev 1981;61:296-434.
67. Boyarsky G, Ganz MB, Sterzel RB, Boron WF: pH regulation in single glomerular mesangial cells. I. Acid extrusion in absence and presence of HCO3-. Am J Physiol 1988;255:C844-C856.
68. Masereel B, Pochet L, Laeckmann D: An overview of inhibitors of Na+/H+ exchanger. Eur J Med Chem 2003;38:547-554. (Pubitemid 36773859)
69. Alvarez D, Vollmann EH, von Andrian UH: Mechanisms and consequences of dendritic cell migration. Immunity 2008;29:325-342.
70. Dieu MC, Vanbervliet B, Vicari A, Bridon JM, Oldham E, Ait-Yahia S, Briere , Zlotnik A, Lebecque S, Caux C: Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 1998;188:373-386. (Pubitemid 28357765)
71. Grinstein S, Cohen S, Goetz JD, Rothstein A: Na+/H+ exchange in volume regulation and cytoplasmic pH homeostasis in lymphocytes. Fed Proc 1985;44:2508-2512. (Pubitemid 15017044)
72. Gulbins E, Welsch J, Lepple-Wienhuis A, Heinle H, Lang F: Inhibition of Fasinduced apoptotic cell death by osmotic cell shrinkage. Biochem Biophys Res Commun 1997;236:517-521. (Pubitemid 27373331)
73. Saha N, Stoll B, Lang F, Haussinger D: Effect of anisotonic cell-volume modulation on glutathione-S-conjugate release, t-butylhydroperoxide metabolism and the pentose-phosphate shunt in perfused rat liver. Eur J Biochem 1992;209:437-444.
74. Saha N, Schreiber R, vom Dahl S, Lang F, Gerok W, Haussinger D: Endogenous hydroperoxide formation, cell volume and cellular K+ balance in perfused rat liver. Biochem J 1993;296:701-707. (Pubitemid 24008187)
75. Haussinger D, Lang F, Gerok W: Regulation of cell function by the cellular hydration state. Am J Physiol 1994;267:E343-E355.
76. Bellocq A, Suberville S, Philippe C, Bertrand F, Perez J, Fouqueray B, herqui G, Baud L: Low environmental pH is responsible for the induction of nitricoxide synthase in macrophages. Evidence for involvement of nuclear factorkappaB activation. J Biol Chem 1998;273:5086-5092. (Pubitemid 28108668)
77. Bidani A, Reisner BS, Haque AK, Wen J, Helmer RE, Tuazon DM, Heming TA: Bactericidal activity of alveolar macrophages is suppressed by V-ATPase inhibition. Lung 2000;178:91-104. (Pubitemid 30247114)
78. Cassatella MA, Flynn RM, Amezaga MA, Bazzoni F, Vicentini F, Trinchieri G: Interferon gamma induces in human neutrophils and macrophages expression of the mRNA for the high affinity receptor for monomeric IgG (Fc gamma R-I or CD64). Biochem Biophys Res Commun 1990;170:582-588. (Pubitemid 20249459)
79. Dieter P, Schulze-Specking A, Karck U, Decker K: Prostaglandin release but not superoxide production by rat Kupffer cells stimulated in vitro depends on Na+/H+ exchange. Eur J Biochem 1987;170:201-206. (Pubitemid 18028457)
80. Nemeth ZH, Mabley JG, Deitch EA, Szabo C, Hasko G: Inhibition of the Na+/H+ antiporter suppresses IL-12 p40 production by mouse macrophages. Biochim Biophys Acta 2001;1539:233-242. (Pubitemid 32566220)
81. Ohmori Y, Reynolds E, Hamilton TA: Modulation of Na+/K+ exchange potentiates lipopolysaccharide-induced gene expression in murine peritoneal macrophages. J Cell Physiol 1991;148:96-105. (Pubitemid 21910131)
82. Orlinska U, Newton RC: Modification of tumor necrosis factor-alpha (TNFalpha) production by the Na+-dependent. Immunopharmacology 1995;30:41-50.
83. Prpic V, Yu SF, Figueiredo F, Hollenbach PW, Gawdi G, Herman B, Uhing RJ, Adams DO: Role of Na+/H+ exchange by interferon-gamma in enhanced expression of JE and I-A beta genes. Science 1989;244:469-471. (Pubitemid 19127506)
84. Rolfe MW, Kunkel SL, Rowens B, Standiford TJ, Cragoe EJ Jr, Strieter RM: Suppression of human alveolar macrophage-derived cytokines by amiloride. Am J Respir Cell Mol Biol 1992;6:576-582.
85. Vairo G, Argyriou S, Bordun AM, Gonda TJ, Cragoe EJ Jr, Hamilton JA: Na+/H+ exchange involvement in colonystimulating factor-1-stimulated macrophage proliferation. Evidence for a requirement during late G1 of the cell cycle but not for early growth factor responses. J Biol Chem 1990;265:16929-16939.
86. Lang F, Ritter M, Woll E, Weiss H, Haussinger D, Hoflacher J, Maly K, Grunicke H: Altered cell volume regulation in ras oncogene expressing NIH fibroblasts. Pflugers Arch 1992;420:424-427.
87. Chakrabarti S, Hoque AN, Karmazyn M: A rapid ischemia-induced apoptosis in isolated rat hearts and its attenuation by the sodium-hydrogen exchange inhibitor HOE 642 (cariporide). J Mol Cell Cardiol 1997;29:3169-3174. (Pubitemid 27510782)
88. Garciarena CD, Caldiz CI, Portiansky EL, Chiappe de Cingolani GE, Ennis IL: Chronic NHE-1 blockade induces an antiapoptotic effect in the hypertrophied heart. J Appl Physiol 2009;106:1325-1331.
89. Li S, Bao P, Li Z, Ouyang H, Wu C, Qian G: Inhibition of proliferation and apoptosis induced by a Na+/H+ exchanger-1 (NHE-1) antisense gene on drug-resistant human small cell lung cancer cells. Oncol Rep 2009;21:1243-1249.
90. Liu Z, Wang S, Zhou H, Yang Y, Zhang M: Na+/H+ exchanger mediates TNF-alpha-induced hepatocyte apoptosis via the calpain-dependent degradation of Bcl-xL. J Gastroenterol Hepatol 2009;24:879-885.
91. Barriere H, Poujeol C, Tauc M, Blasi JM, Counillon L, Poujeol P: CFTR modulates programmed cell death by decreasing intracellular pH in Chinese hamster lung fibroblasts. Am J Physiol Cell Physiol 2001;281:C810-C824.
92. Lang F, Madlung J, Bock J, Lukewille U, Kaltenbach S, Lang KS, Belka C, anger CA, Lang HJ, Gulbins E, Lepple-Wienhues A: Inhibition of Jurkat-Tlymphocyte Na+/H+-exchanger by CD95(Fas/Apo-1)-receptor stimulation. Pflugers Arch 2000;440:902-907.
93. Maeno E, Takahashi N, Okada Y: Dysfunction of regulatory volume increase is a key component of apoptosis. FEBS Lett 2006;580:6513-6517. (Pubitemid 44750945)
94. Chouchana L, Narjoz C, Beaune P, Loriot MA, Roblin X: Review article: benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease. Aliment Pharmacol Ther 2012;35:15-36.
95. Duley JA, Florin TH: Thiopurine therapies: problems, complexities, and progress with monitoring thioguanine nucleotides. Ther Drug Monit 2005;27:647-654. (Pubitemid 41437645)
96. Gearry RB, Barclay ML: Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease. J Gastroenterol Hepatol 2005;20:1149-1157. (Pubitemid 41602556)